未登录

C

Christopher W. Mangieri

Wake Forest University

H指数:13

被引数:602

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Infected Endovascular Stent Graft Leading to Degradation of the Superficial Femoral Artery

感染性腔内支架移植物导致股浅动脉退化

Surgical Infections

IF1.4

2025-10-010

PRE

ASO Visual Abstract: Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) of Extraperitoneal Abdominal Disease, Is it Appropriate?

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2025-03-010

PRE

Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) of Extraperitoneal Abdominal Disease, is it Appropriate?

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2025-02-041

OAAI

ASO Author Reflections: Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) of Extraperitoneal Abdominal Disease, a Likely Common Practice but Infrequently Reported

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2025-02-030

OAAI

ASO Visual Abstract: Long-Term Survival in Patients Treated with Cytoreduction and Heated Intraperitoneal Chemotherapy for Peritoneal Mesothelioma at a Single High-Volume Center

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2023-02-230

PRE

Long-Term Survival in Patients Treated with Cytoreduction and Heated Intraperitoneal Chemotherapy for Peritoneal Mesothelioma at a Single High-Volume Center

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2023-02-0811

OA

ASO Visual Abstract: Exposure to Neoadjuvant Oxaliplatin-Containing Chemotherapy; Does It Affect Intraperitoneal Hyperthermic Chemotherapy Perfusion?

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2023-01-210

OA

ASO Author Reflections: Neoadjuvant Oxaliplatin Therapy for Peritoneal Carcinomatosis, Any Impact on Subsequent Hyperthermic Intraperitoneal Chemotherapy Perfusion?

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2023-01-050

PRE

Exposure to Neoadjuvant Oxaliplatin-Containing Chemotherapy, Does it Effect Intraperitoneal Hyperthermic Chemotherapy Perfusion?

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2022-12-091

PRE

Management of peritoneal surface metastases from colorectal cancer: Cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, pressurized intraperitoneal chemotherapy, and beyond

FRONTIERS IN ONCOLOGY

IF3.3

2022-11-082

OAAI

ASO Author Reflections: Evaluating HIPEC Switch for Repeat CRS-HIPEC, Time to End a Common Practice?

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2022-09-060

PRE

ASO Visual Abstract: Switching Perfusion Agents for Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy, Surgical Dogma or Evidence-Based Practice?

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2022-09-040

OA

Switching Perfusion Agents for Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: Surgical Dogma or Evidence-Based Practice?

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2022-08-155

PRE

Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Cancers with Peritoneal Metastasis: A 30-year Institutional Experience

腹腔热灌注化疗对腹膜转移癌症的重复细胞减灭术: 30年的机构经验

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2022-03-1414

OA

ASO Visual Abstract: Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Cancers with Peritoneal Metastasis-A 30-year Institutional Experience

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2022-03-071

PRE

Timing of Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Recurrent Low-Grade Appendiceal Mucinous Neoplasms

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2022-03-076

OA

ASO Visual Abstract: Timing of Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Recurrent Low-Grade Appendiceal Mucinous Neoplasms

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2022-03-060

PRE

Prognostic Effect of Aberrant Right Hepatic Artery with Pancreaticoduodenectomy: Focus on Hepatic Recurrence7

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2022-02-206

PRE

ASO Author Reflections: Aberrant Right Hepatic Artery Anatomy, an Independent Prognostic Factor for Hepatic Recurrence of Pancreatic Cancer

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2022-02-110

PRE

ASO Visual Abstract: Prognostic Effect of Aberrant Right Hepatic Artery with Pancreaticoduodenectomy-Focus on Hepatic Recurrence

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2022-02-071

OA